Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model - Wikidata - awgldk - TriplyDB

Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model

Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model

http://www.wikidata.org/entity/Q36821149

about

Advances in Cancer Immunotherapy in Solid Tumors Immune checkpoints and their inhibition in cancer and infectious diseases.Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders.The Unique Molecular and Cellular Microenvironment of Ovarian Cancer Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.The latest animal models of ovarian cancer for novel drug discovery.Revisiting ovarian cancer microenvironment: a friend or a foe?Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells.

P2860

Q28080113-CC1B1B8C-DB30-4E32-983B-740B542261E3 Q38845026-EEBD23C3-654C-4BDE-8DD1-72EF0CB53116 Q39055861-0B8CD4E5-040C-4B8E-B9AB-F0894277BDC6 Q39169603-687F3458-4474-46B4-B162-2E0932D65420 Q43025486-F85F02AE-7979-428B-B6C1-0A1E6E51671D Q47325431-692F51FC-92DB-47E6-B0FC-6C0EF9D9D25F Q47553013-0E22692D-7451-4D86-9D3B-7E64A352549A Q47773956-E50CAA3B-2BD0-41C3-A481-9B4660202D36 Q47880159-237D7210-E1E3-435C-B4BD-D25C1FF92DB2 Q49539698-1121AE63-F1C3-4C97-A367-EB783AECF9DE Q54958210-330D92F4-1383-4A9A-BC93-7C792BF8376B

P2860

Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model

http://www.wikidata.org/entity/Q36821149

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Anti-CCR4 monoclonal antibody ...... enograft humanized mouse model

@en

type

label

Anti-CCR4 monoclonal antibody ...... enograft humanized mouse model

@en

prefLabel

Anti-CCR4 monoclonal antibody ...... enograft humanized mouse model

@en

P1433

Q36821149-9AA061CB-28EF-4DC3-ACD4-01A9D18D3AC7

P1476

Q36821149-44BC30BC-CDBB-46B7-9E2F-C1D76AFB5995

P2093

Q36821149-0E1C62F0-12CE-400B-88FB-FACE56A62813

Q36821149-4D3966C6-C81D-4D50-AB91-06A285CE8A4D

Q36821149-78CAC78D-D881-494F-9C71-FADC56C124A2

Q36821149-816BE10F-0376-4890-A113-D3D02035AAAC

Q36821149-8C2D1083-7EA7-4C72-8831-3C2222A1B605

Q36821149-B97AF7E6-FD8D-4149-A80F-B1AA73A3C9A2

Q36821149-D8229D1C-849B-4E1E-98CA-BC06B9878AB2

Q36821149-F275108D-FA6A-4AA9-90CC-234BBF47B065

P2860

Q36821149-022DCFE3-24C7-4E90-89BB-1BB8F58AA9A1

Q36821149-04E55B4A-5A0D-4549-8BFC-88EF765E54E6

Q36821149-06826AEA-B298-48E2-8208-6A9ACFBAD5E7

Q36821149-0777DB44-3323-4D53-BF63-34792C4D7F3B

Q36821149-0C049472-F958-428C-A0E1-5C2535D5813F

Q36821149-0F98B7CA-8C52-47F8-B838-C8F48A5F5B0F

Q36821149-12AC606F-8224-4877-ACDB-24E3D61F5091

Q36821149-16DA74B8-8A80-4554-9214-7EDDDC60DC02

Q36821149-17FBA061-E580-4E74-9564-64044C5FD8FF

Q36821149-1854F076-B3BD-494A-849F-42ACE1ED43D2

P304

Q36821149-16928E12-E00C-42F7-AEB3-F24846838DDC

P31

Q36821149-1D29C50D-1B91-4704-828F-8BE45F5BFAEA

P356

Q36821149-33BAF296-23B1-436D-9CE2-97A1992CF2F7

P433

Q36821149-41E72E5A-9B4F-468B-8AE2-E8E19E7CEE8C

P478

Q36821149-F4BBE345-870E-4B50-BCCC-5C3020FCAA71

P50

Q36821149-795D4399-646A-4EC0-A364-9653015E6137

P577

Q36821149-F7B05114-992F-44F8-8765-92C6EA951204

P698

Q36821149-4D631B48-5CEB-49E4-9C53-9ACD64E1D858

P921

Q36821149-21302614-6543-4C4B-B03E-1D5CD18962B5

Q36821149-4B94E591-2F8A-4F57-90DA-C0D3704E50C7

P932

Q36821149-8F2BFC93-A249-4EDA-9E16-3FF6E76BEA69

P356

2162402X.2015.1090075

P1433

P1476

Anti-CCR4 monoclonal antibody ...... enograft humanized mouse model

@en

P2093

Calum Goudie

http://www.w3.org/2001/XMLSchema#string

De-Kuan Chang

http://www.w3.org/2001/XMLSchema#string

Eric Peterson

http://www.w3.org/2001/XMLSchema#string

Jiusong Sun

http://www.w3.org/2001/XMLSchema#string

Joyce F Liu

http://www.w3.org/2001/XMLSchema#string

Quan Zhu

http://www.w3.org/2001/XMLSchema#string

Ursula Matulonis

http://www.w3.org/2001/XMLSchema#string

Wayne A Marasco

http://www.w3.org/2001/XMLSchema#string

P2860

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Diversity and modularity of G protein-coupled receptor structures

Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells

Nivolumab plus ipilimumab in advanced melanoma.

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer

Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

How regulatory T cells work

P304

e1090075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2015.1090075

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27141347

http://www.w3.org/2001/XMLSchema#string

P921

P932

4839340

http://www.w3.org/2001/XMLSchema#string